Biologics

MiMedx Provides Update On Its Reimbursement Coverage
Biologics

MiMedx Provides Update On Its Reimbursement Coverage

MARIETTA, Ga., Nov. 21, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, provided a reimbursement update today. Parker H. “Pete” Petit, Chairman and Chief Executive Officer, said “With […]

BONESUPPORT™ Signs Commercialization Agreement for the Italian Market
Biologics Top Stories

BONESUPPORT™ Signs Commercialization Agreement for the Italian Market

Lund, Sweden, 08.00 CET, 20 November 2017  – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform today announces it has signed a second distribution agreement for Italy with Citieffe Srl to […]

Invibio Investing to Accelerate Innovation for Medical Device Companies
Biologics Top Stories

Invibio Investing to Accelerate Innovation for Medical Device Companies

THORNTON CLEVELEYS, UNITED KINGDOM (PRWEB) NOVEMBER 16, 2017 Invibio Biomaterial Solutions has implemented a series of investments to help achieve the best possible clinical outcomes and lower total healthcare costs, a challenge faced by both the medical profession and industry, including medical device companies, globally. By assisting medical device companies to change […]

MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
Biologics Regulatory

MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document

MARIETTA, Ga., Nov. 17, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that the Food and Drug Administration (FDA) issued numerous Final and Draft Guidance documents.  Among […]

OrthoPediatrics Corp. to Start Distributing Bioretec Devices via Private Label
Biologics Extremities Sports Medicine Top Stories

OrthoPediatrics Corp. to Start Distributing Bioretec Devices via Private Label

WARSAW, Ind., Nov. 13, 2017 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, and Bioretec Ltd. (“Bioretec”), announced today that they have amended their existing distribution agreement in order for OrthoPediatrics to market and sell Bioretec’s unique, bioresorbable orthopaedic bone and soft-tissue […]

Solvay helps DiFusion Technologies innovate new ZFUZE osteoconductive PEEK composite for spinal implants
Biologics Spine

Solvay helps DiFusion Technologies innovate new ZFUZE osteoconductive PEEK composite for spinal implants

Alpharetta, Ga., Nov. 9, 2017 —Solvay, a leading global supplier of specialty polymers, announced that medical device-maker DiFusion Technologies chose Zeniva® ZA-500 polyetheretherketone (PEEK) as the base polymer for its ZFUZE osteoconductive PEEK composite for spinal implants. The new compound exhibited large areas of new bone formation on all bone […]

AlloSource Announces Bob Lay As Chief Operating Officer
Biologics Top Stories

AlloSource Announces Bob Lay As Chief Operating Officer

CENTENNIAL, Colo., Nov. 7, 2017 /PRNewswire-USNewswire/ — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Bob Lay as Chief Operating Officer. With over 20 years of experience in both finance and […]

Xtant Medical Enters into a Distribution Agreement with curasan, Inc. Bringing Matriform™ to Market
Biologics

Xtant Medical Enters into a Distribution Agreement with curasan, Inc. Bringing Matriform™ to Market

BELGRADE, Mont., Nov. 01, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced it has entered into a distribution agreement with curasan, Inc. adding a premium line of synthetic scaffolds to its biologics portfolio. Matriform, […]

SeaSpine Announces Limited Commercial Launch of OsteoStrand™ Demineralized Bone Fibers
Biologics Spine Top Stories

SeaSpine Announces Limited Commercial Launch of OsteoStrand™ Demineralized Bone Fibers

CARLSBAD, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries for its OsteoStrand™ Demineralized Bone Fibers. The first implantations were completed by […]

MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions
Biologics Regulatory Top Stories

MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions

MARIETTA, Ga., Nov. 1, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that the Company has agreed to a confidential settlement of the lawsuit the Company […]

Global Spine Orthopaedic Devices Market 2017-2023 – Increase Usage of Orthopedic Biomaterials in Spine Surgery
Biologics Spine

Global Spine Orthopaedic Devices Market 2017-2023 – Increase Usage of Orthopedic Biomaterials in Spine Surgery

DUBLIN, November 1, 2017 /PRNewswire/ — The “Global Spine Orthopaedic Devices Market: Drivers, Restraints, Opportunities; Trends and Opportunities to 2023”report has been added to Research and Markets’ offering. The “Global Spine Orthopedic Devices Market” is Estimated to Witness a CAGR of 6.23% During 2017-2023 The market is dominated by the Spine Implants segment with the […]

Arthrosurface acquires an acellular dermal technology from WASAS, LLC
Biologics

Arthrosurface acquires an acellular dermal technology from WASAS, LLC

FRANKLIN, Mass., Oct. 30, 2017 /PRNewswire/ — Arthrosurface, Inc. announced today that it has completed the acquisition of an acellular dermal stabilization device technology, including the intellectual property rights to and associated with this technology, from WASAS, LLC based in Fort Lauderdale, Florida. Arthrosurface plans to use this technology to develop and market a […]